07.10 15:57 | dpa-AFX: GE HealthCare Joins Thera4Care |
07.10 15:05 | dpa-AFX: *GE HEALTHCARE LAUNCHES THERA4CARE INITIATIVE TO ENHANCE PATIENT ACCESS TO THERANOSTICS IN EUROPE |
07.10 09:26 | dpa-AFX: GE HealthCare Reports Results From Phase 1 Study Of Manganese-based Macrocyclic MRI Contrast Agent |
07.10 08:50 | dpa-AFX: *GE HEALTHCARE ANNOUNCES PHASE I RESULTS FOR FIRST-OF-ITS-KIND MANGANESE-BASED MRI CONTRAST AGENT |
07.10 08:30 | BUSINESS WIRE: GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent |
26.09 15:43 | dpa-AFX: *GE HEALTHCARE -2,8% NACH GUTEM LAUF - UBS SENKT AKTIE AUF 'SELL' |
26.09 13:09 | dpa-AFX: *GE HEALTHCARE VORBÖRSLICH -1,3% NACH GUTEM LAUF - UBS SENKT AUF 'SELL' |
26.09 13:02 | dpa-AFX: ANALYSE-FLASH: UBS senkt GE Healthcare auf 'Sell' - Teurer als Siemens Health |
26.09 12:17 | dpa-AFX: *UBS CUTS GE HEALTHCARE TO 'SELL' (NEUTRAL) - PRICE TARGET 74 (84) USD |
26.09 12:17 | dpa-AFX: *UBS SENKT GE HEALTHCARE AUF 'SELL' (NEUTRAL) - ZIEL 74 (84) USD |
18.09 22:56 | dpa-AFX: *GE HEALTHCARE TECHNOLOGIES INC. (GEHC) DECLARES $ 0.03 DIVIDEND FOR Q3 24, RECORD DATE 10/18/2024 |
13.09 04:10 | dpa-AFX: GE HealthCare Technologies Prices Upsized Secondary Offering Of 15 Mln Shares At $86.00/shr |
05.09 18:09 | dpa-AFX: GE HealthCare To Present At Morgan Stanley Global Healthcare Conference; Webcast At 1:05 PM ET |
04.09 15:19 | dpa-AFX: GE HealthCare Technologies To Present At Wells Fargo Healthcare Conference; Webcast At 10:15 AM ET |
31.07 15:48 | dpa-AFX: *GE HEALTHCARE +1,6% NACH ZAHLEN - SENKT WACHSTUMSZIEL FÜR 2024 |
31.07 13:47 | dpa-AFX: ROUNDUP 2: Schwaches China-Geschäft bremst Siemens Healthineers - Am Dax-Ende |
31.07 13:47 | ROUNDUP 2: Schwaches China-Geschäft bremst Siemens Healthineers - Am Dax-Ende |
31.07 13:43 | dpa-AFX: ROUNDUP 2: Schwaches China-Geschäft bremst Siemens Healthineers - Am Dax-Ende |
31.07 13:05 | dpa-AFX: *GE HEALTHCARE VORBÖRSLICH -5,6% - SENKT WACHSTUMSZIEL FÜR 2024 |
31.07 12:49 | dpa-AFX: GE HealthCare Backs FY Adj. EPS View, Cuts Organic Sales View As Q2 Revenues Miss Street; Stock Down |
|